SILO PHARMA, INC. Stock Issued During Period, Value, Other
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- SILO PHARMA, INC. stock issued during period, value, other for the quarter ending 2025-09-30 was $518.23K.
- SILO PHARMA, INC. stock issued during period, value, other for the quarter ending 2024-06-30 was $1.67M.
- SILO PHARMA, INC. stock issued during period, value, other for the quarter ending 2021-03-31 was $3.79M.
- SILO PHARMA, INC. stock issued during period, value, other for fiscal 2021 was $3.79M.
- SILO PHARMA, INC. stock issued during period, value, other for fiscal 2019 was $110.00K.
| Period end | Stock Issued During Period, Value, Other 3 month | Stock Issued During Period, Value, Other 12 month |
|---|---|---|
| 2025-12-31 | $518.23K POS AM · filed 2026-04-14 | |
| 2025-09-30 | $518.23K 10-Q · filed 2025-11-13 | |
| 2024-06-30 | $1.67M 10-Q · filed 2025-08-13 | |
| 2021-12-31 | $3.79M 10-K · filed 2023-03-24 | |
| 2021-03-31 | $3.79M 10-Q · filed 2022-11-10 | |
| 2019-12-31 | $110.00K 10-K/A · filed 2021-05-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |